FOLH1 and prostate carcinoma: 68Ga-PSMA PET is recognized for its high sensitivity in detecting prostate cancer cells, making it particularly useful in identifying metastatic or recurrent disease, while mpMRI excels in detailed soft-tissue characterization, which is crucial for local staging and guiding biopsy (12).